|
|
Volumn 7, Issue 315, 2015, Pages
|
|
Is all cancer therapy immunotherapy?
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANSAMITOCIN P 3;
BLOCKING ANTIBODY;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY;
GAMMA INTERFERON;
INTERLEUKIN 10;
INTERLEUKIN 1BETA;
INTERLEUKIN 4;
MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;
MACROPHAGE INFLAMMATORY PROTEIN 1BETA;
PROGRAMMED CELL DEATH PROTEIN 1 ANTIBODY;
PROGRAMMED DEATH 1 RECEPTOR;
RANTES;
TRASTUZUMAB;
TRASTUZUMAB EMTANSINE;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
CANCER VACCINE;
ADAPTIVE IMMUNITY;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
ANTIGEN PRESENTING CELL;
ARTICLE;
BREAST CANCER;
BREAST METASTASIS;
CANCER CELL DESTRUCTION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER INFILTRATION;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL CYCLE ARREST;
CELL DEATH;
CYTOKINE PRODUCTION;
DRUG MECHANISM;
DRUG POTENTIATION;
HUMAN;
LYMPHOCYTIC INFILTRATION;
NONHUMAN;
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
TH1 CELL;
TUMOR ASSOCIATED LEUKOCYTE;
TUMOR MICROENVIRONMENT;
IMMUNOTHERAPY;
NEOPLASMS;
CANCER VACCINES;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
|
|
EID: 84954426220
PISSN: 19466234
EISSN: 19466242
Source Type: Journal
DOI: 10.1126/scitranslmed.aad7661 Document Type: Article |
|
Times cited : (15)
|
|
References (6)
|
